Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Analyst Ratings

TNXP's stock price has decreased by -94.01% in the past year and price targets may not have had time to catch up.

• Total Analysts: 2
• Consensus Rating: Strong Buy
• Price Target: $5.50
• Upside: +2,897.28%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert Dawson James	Dawson James	Strong Buy Initiates $3	Strong Buy	Initiates	$3	+1,534.88%	Feb 28, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $18 → $8	Strong Buy	Maintains	$18 → $8	+4,259.67%	Aug 1, 2023
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $6.5 → $18	Strong Buy	Maintains	$6.5 → $18	+9,709.26%	Jun 2, 2023
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Reiterates $41	Strong Buy	Reiterates	$41	+22,036.24%	Jan 12, 2023
Robert LeBoyer Noble Capital Markets	Noble Capital Markets	Buy Initiates $120	Buy	Initiates	$120	+65,295.10%	Apr 18, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $2 → $3	Strong Buy	Maintains	$2 → $3	+1,534.88%	Aug 31, 2021
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $4 → $2	Strong Buy	Maintains	$4 → $2	+989.92%	Aug 11, 2021
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $3 → $4	Strong Buy	Maintains	$3 → $4	+2,079.84%	Feb 25, 2021
Scott Henry Roth Capital	Roth Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Apr 18, 2019
Scott Henry Roth Capital	Roth Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 27, 2018
Scott Henry Roth Capital	Roth Capital	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Aug 18, 2017